Publications by authors named "Roland B Walter"

Claim this Profile
2
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party.
Jacqueline Cloos, Peter J M Valk, Christian Thiede, Konstanze Döhner, Gail J Roboz, Roland B Walter

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During Treatment.
Matthew Wu, Kathryn Russell, Carole M Shaw, Anna B Halpern, Cristina Ghiuzeli, Roland B Walter

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziftomenib in Relapsed or Refractory -Mutated AML.
Eunice S Wang, Pau Montesinos, James Foran, Harry Erba, Eduardo Rodríguez-Arbolí, Roland B Walter

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy.
Hannah R Abrams, Helene Starks, Lindsey Bandini, Terry Harrington, Mary-Elizabeth M Percival, Roland B Walter

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology-Directed Therapy for Myeloid/Lymphoid Neoplasms with Rearrangements.
Vivian G Oehler, Roland B Walter

NEJM Evid· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm.
Suravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, Kim Quach, Eva Gill, Roland B Walter

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia.
Margery Gang, Megan Othus, Anne-Chloe Olix, Kate A Markey, Derek L Stirewalt, Roland B Walter

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old.
Roland B Walter, Victoria Potter, Charles Craddock

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies.
Sheryl Y T Lim, Frances M Cole, George S Laszlo, Margaret C Lunn-Halbert, Jenny Huo, Roland B Walter

Haematologica· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Adriano Venditti, Raffaele Palmieri, Luca Maurillo, Christoph Röllig, Agnieszka Wierzbowska, Roland B Walter

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques.
Nicholas E Petty, Stefan Radtke, Greta Kanestrom, Emily Fields, Olivier Humbert, Roland B Walter

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulators of relapse risk in adults allografted for acute myeloid leukemia in measurable residual disease-positive remission.
Margery Gang, Megan Othus, Brenda M Sandmaier, Chris Davis, Ryan S Basom, Roland B Walter

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632).
Frances M Cole, George S Laszlo, Margaret C Lunn-Halbert, Allie R Kehret, Patrick A Zweidler-McKay, Roland B Walter

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biobanking and consent to future biospecimen use among adults enrolled in SWOG trials from 2000 to 2024.
Daniel J Olivieri, Alexis Berridge-Green, Megan Othus, Jerald P Radich, Anjali S Advani, Roland B Walter

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samples.
Suravi Raychaudhuri, Hakan Gem, Kevin Chung, Jeffrey S McLean, Kristopher A Kerns, Roland B Walter

NPJ Biofilms Microbiomes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy.
Florence Borot, Olivier Humbert, Jeffrey T Ehmsen, Emily Fields, Sajeev Kohli, Roland B Walter

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AML.
Phuong T Vo, Brenda M Sandmaier, Megan Othus, Naveed Ali, Eduardo Rodríguez-Arbolí, Roland B Walter

Bone Marrow Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease as predictor of post-day +100 relapses after allografting in adult AML.
Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano, Roland B Walter

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia.
Corentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí, Megan Othus, Effie W Petersdorf, Roland B Walter

Leukemia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
Margery Gang, Megan Othus, Roland B Walter

Cells· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia.
Khushboo V Pal, Megan Othus, Zahra Ali, Katherine Russell, Carole Shaw, Roland B Walter

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy.
Geoffrey L Uy, Vinod Pullarkat, Praneeth Baratam, Robert K Stuart, Roland B Walter

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Eunice S Wang, Ghayas C Issa, Harry P Erba, Jessica K Altman, Pau Montesinos, Roland B Walter

Lancet Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders.
Sheryl Y T Lim, Jenny Huo, George S Laszlo, Frances M Cole, Allie R Kehret, Roland B Walter

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy.
Salvatore Fiorenza, Sheryl Y T Lim, George S Laszlo, Erik L Kimble, Tinh-Doan Phi, Roland B Walter

Mol Ther Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis